HomeMANKIND • NSE
add
Mankind Pharma Ltd
Nakaraang pagsara
₹2,477.45
Sakop ng araw
₹2,460.65 - ₹2,534.10
Sakop ng taon
₹1,901.05 - ₹3,054.80
Market cap
1.03T INR
Average na Volume
654.81K
P/E ratio
47.06
Dividend yield
-
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 32.30B | 23.90% |
Gastos sa pagpapatakbo | 16.57B | 29.21% |
Net na kita | 3.80B | -16.20% |
Net profit margin | 11.77 | -32.40% |
Kita sa bawat share | 9.44 | -16.53% |
EBITDA | 7.34B | 27.38% |
Aktuwal na % ng binabayarang buwis | 22.68% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 47.27B | 103.22% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 107.89B | — |
Natitirang share | 402.36M | — |
Presyo para makapag-book | 9.39 | — |
Return on assets | — | — |
Return on capital | 14.14% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 3.80B | -16.20% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Itinatag
1991
Website
Mga Empleyado
19,540
